AlphaMaven

Hedge Funds ◦ Managed Futures ◦ Crypto Funds ◦ Venture Capital ◦ Private Equity ◦ Real Estate ◦ Cannabis

AlphaMaven
(formerly HedgeMaven)

AlphaMaven
(formerly HedgeMaven)

PRIVATE INVESTMENT NETWORK
Free ◦ Private ◦ Secure

Most Visited Alternative Investment Industry Website. Over 40,000 visitors per month

3w ago hedgeco Views: 255

(CNBC) Gilead Sciences reported stronger-than-expected third-quarter earnings on Wednesday as sales of its coronavirus treatment remdesivir touted by President Donald Trump drove revenue up by 17% from last year. Gilead’s antiviral drug remdesivir, selling under the brand name Veklury, last week became the first and only treatment granted full approval by the U.S. Food and Drug Administration for treating Covid-19 patients. To read this article: -

Hedge Fund Headlines:

Hedge Fund
Join the AlphaMaven Private Investment Network

Exclusively For:

Qualified Investors & Knowledgeable Industry Participants

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates